Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Join Taipei City's Thriving Health Industry: Registration for "Win A Greater Health" Pitch Contest Starts Now! 2023-07-18 11:35
Antengene Announces First Patient Dosed in the Nivolumab Combination Portion of the Clinical Study Evaluating the ERK1/2 Inhibitor ATG-017 in Patients with Advanced Solid Tumors in the United States 2023-07-18 08:30
ALZHEIMER'S ASSOCIATION STATEMENT ON DONANEMAB PHASE 3 DATA REPORTED AT AAIC 2023 2023-07-17 21:15
Antengene Announces XPOVIO® Regulatory Approval in Hong Kong for the Treatment of Relapsed and/or Refractory Multiple Myeloma 2023-07-17 08:30
Red Marrow Peptide-A Major Breakthrough in Human Health Engineering 2023-07-14 12:51
Menarini Silicon Biosystems announces the launch of its new CELLSEARCH® CTC test with the DLL3 biomarker for small cell lung cancer 2023-07-13 20:00
Sirnaomics to Present Latest Developments on Two Proprietary Delivery Platforms at Upcoming Industry Conferences 2023-07-12 20:45
Raya Therapeutic announces early-stage R&D collaboration with argenx 2023-07-12 19:07
Biosyngen's First-in-class Cell Therapy BRG01 Receives FDA Fast Track Designation 2023-07-12 13:38
Creating the China-Singapore Translational Medicine Center - Biosyngen's pursuit to be a leading player in the CGT industry globally hits new milestone. 2023-07-12 10:32
Sciwind Biosciences Announces Publication of Discovery, Preclinical, and Phase 1 Clinical Trial Results of Ecnoglutide (XW003) in Molecular Metabolism 2023-07-12 10:00
GI Dynamics Announces Company Rebrand as Morphic Medical® Reintroducing Flagship Product as RESET® 2023-07-12 07:12
Race executes global license agreement with City of Hope to access FTO IP 2023-07-11 07:30
Rx-360 Expands Trademark Portfolio to Japan 2023-07-10 18:00
Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking Medicine is Set to Revolutionize Healthcare with a 4-Day Hackathon 2023-07-10 15:19
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors 2023-07-10 10:24
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years 2023-07-07 19:43
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001) 2023-07-07 15:52
CARING PHARMACY CELEBRATES UNIFIED CARING MEMBERSHIP PROGRAMME WITH GEORGETOWN PHARMACY AND WELLINGS PHARMACY 2023-07-06 18:00
MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea 2023-07-06 09:00
1 28 29 30 31 32 230